$ZTS News

How Is Zoetis’ Stock Performance Compared to Other Healthcare Stocks?

Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff?

Zoetis Lawsuits Challenge Companion Animal Outlook Yet Valuation Screens As Undemanding

Zoetis Inc. (ZTS): Among The Most Oversold S&P 500 Stocks So Far in 2026

Here’s Why Zoetis (ZTS) Is one of the Best Wide Moat Stocks to Buy According to Wall Street Analysts

Zoetis Inc. (ZTS) Presents at Stifel Jaws & Paws Conference 2026 Transcript

Argus Research Downgrades Zoetis (ZTS)

Argus Research Downgrades Zoetis to Hold

2 Profitable Stocks Worth Your Attention and 1 We Find Risky

Stifel Maintains Hold on Zoetis, Lowers Price Target to $95

Zoetis Probe Tests Guidance Credibility And Long Term Investor Confidence

Zoetis to Participate in Upcoming Investor Conferences

Zoetis Declares Third Quarter 2026 Dividend

FDA Issued Emergency Use Authorization For Dectomax/Dectomax-CA1 (Doramectin Injection) Injectable Solution; Issues Emergency Use Authorization For Over-The-Counter Injectable Drug For New World Screwworm In Dairy Cattle, Horses, Swine, Sheep, And Deer

Zoetis Inc (NYSE:ZTS): A Dividend Growth Stock with Strong Profitability and Attractive Valuation

Citigroup Maintains Buy on Zoetis, Lowers Price Target to $112

5 Revealing Analyst Questions From Zoetis’s Q1 Earnings Call

Zoetis (ZTS) Valuation Reset After Q1 Earnings Miss And Guidance Cut

Jim Cramer Calls Zoetis a “Quality Company” Despite Recent Declines

Here is Why Zoetis (ZTS) is One of the Best NYSE Stocks According Analysts